10-87863704-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000314.8(PTEN):c.-766G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PTEN
NM_000314.8 5_prime_UTR
NM_000314.8 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0900
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.-766G>A | 5_prime_UTR_variant | 1/9 | ENST00000371953.8 | NP_000305.3 | ||
PTEN | NM_001304717.5 | c.-246G>A | 5_prime_UTR_variant | 1/10 | NP_001291646.4 | |||
PTEN | NM_001304718.2 | c.-1470G>A | 5_prime_UTR_variant | 1/9 | NP_001291647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.-766G>A | 5_prime_UTR_variant | 1/9 | 1 | NM_000314.8 | ENSP00000361021 | P1 | ||
ENST00000692337.1 | downstream_gene_variant | ENSP00000509326 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 241082Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 122542
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
241082
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
122542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PTEN-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 15, 2023 | The PTEN c.-765G>A variant is located in the 5' untranslated region. This variant (also referred to as -764A-G, c.-764G>A, and -764G/A using alternative nomenclature) occurs in the pre-coding region of the gene. This variant has been identified in individuals affected with Cowden syndrome who also had breast or endometrial cancer (Zhou et al. 2003. PubMed ID: 12844284; Teresi et al. 2007. PubMed ID: 17847000). In a reporter assay, this variant demonstrated ~50% decrease in luciferase activity compared to wild type; however, luciferase mRNA expression was equal to that of wild type in cells transfected with the wild type construct (Teresi et al. 2007. PubMed ID: 17847000). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In ClinVar, this variant is interpreted as uncertain by an expert panel (https://www.ncbi.nlm.nih.gov/clinvar/variation/7844/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 28, 2019 | The c.-765G>A variant is located in the 5' untranslated region (5’UTR) of the PTEN gene. This variant results from a G to A substitution 765 nucleotides upstream from the first translated codon. In one study, this variant was described in an individual with breast cancer (Zhou XP et al. Am J Hum Genet. 2003;73(2):404-411). In another study, this variant was described in a patient with benign breast neoplasia and endometrial cancer (Teresi RE et al. Am. J. Hum. Genet. 2007 Oct;81(4):756-67). This same study demonstrates that PTEN transcription efficiency and mRNA stability were not compromised, although the c.-765G>A alteration did result in a decrease of luciferase activity as measured by an in vitro reporter assay. In addition, in silico analysis predicted that the mRNA secondary structure of the PTEN promoter was altered. Based on the above evidence, the authors hypothesized that the c.-765G>A variant would result in a significant decrease in protein expression. Of note, this variant is also known as -764G>A in published literature. In addition, this nucleotide position is highly conserved in available vertebrate species. Since supporting evidence for this variant is limited at this time, the clinical significance of this alteration is unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at